RT Journal Article
SR Electronic
T1 Description of a University COVID-19 Outbreak and Interventions to Disrupt Transmission, Wisconsin, August – October 2020
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.05.07.21256834
DO 10.1101/2021.05.07.21256834
A1 Currie, Dustin W.
A1 Moreno, Gage K.
A1 Delahoy, Miranda J.
A1 Pray, Ian W.
A1 Jovaag, Amanda
A1 Braun, Katarina M.
A1 Cole, Devlin
A1 Shechter, Todd
A1 Fajardo, Geroncio C.
A1 Griggs, Carol
A1 Yandell, Brian S.
A1 Goldstein, Steve
A1 Bushman, Dena
A1 Segaloff, Hannah E.
A1 Kelly, G. Patrick
A1 Pitts, Collin
A1 Lee, Christine
A1 Grande, Katarina M.
A1 Kita-Yarbro, Amanda
A1 Grogan, Brittany
A1 Mader, Sara
A1 Baggott, Jake
A1 Bateman, Allen C.
A1 Westergaard, Ryan P.
A1 Tate, Jacqueline E.
A1 Friedrich, Thomas C.
A1 Kirking, Hannah L.
A1 O’Connor, David H.
A1 Killerby, Marie E.
YR 2021
UL http://medrxiv.org/content/early/2021/05/10/2021.05.07.21256834.abstract
AB University settings have demonstrated potential for COVID-19 outbreaks, as they can combine congregate living, substantial social activity, and a young population predisposed to mild illness. Using genomic and epidemiologic data, we describe a COVID-19 outbreak at the University of Wisconsin (UW)–Madison. During August – October 2020, 3,485 students tested positive, including 856/6,162 students living in residence halls. Case counts began rising during move-in week for on-campus students (August 25-31, 2020), then rose rapidly during September 1-11, 2020. UW-Madison initiated multiple prevention efforts, including quarantining two residence halls; a subsequent decline in cases was observed. Genomic surveillance of cases from Dane County, where UW-Madison is located, did not find evidence of transmission from a large cluster of cases in the two residence halls quarantined during the outbreak. Coordinated implementation of prevention measures can effectively reduce SARS-CoV-2 spread in university settings and may limit spillover to the community surrounding the university.Competing Interest StatementThe findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. Use of trade names is for identification only and does not imply endorsement by the Centers for Disease Control and Prevention.Clinical TrialN/A.Funding StatementG.K.M. is supported by an NLM training grant to the Computation and Informatics in Biology and Medicine Training Program (NLM 5T15LM007359). This work was funded in part by the U.S. Centers for Disease Control and Prevention Contract #75D30120C09870: Defining the Role of College Students in SARS-CoV-2 Spread in the Upper Midwest.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:A waiver of HIPAA Authorization was obtained by the Western Institutional Review Board (WIRB #1-1290953-1) to obtain the clinical specimens for whole genome sequencing. This analysis was reviewed by CDC and was conducted consistent with applicable federal law and CDC policy. These activities were determined to be non-research public health surveillance by the Institutional Review Board at UW-Madison.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll sequencing data is available on www.gisaid.org. Scripts for sequence data analysis is available at https://github.com/gagekmoreno/SARS-CoV-2-at-UW_Madison. https://github.com/gagekmoreno/SARS-CoV-2-at-UW_Madison